Company / Gross Profit
Viatris Gross Profit History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$5.0B
FY2025
5-year range
$3.8B / $6.4B
FY2021-FY2025
Trend
-10.8%
vs FY2024
Sector context
#3 of 29
Health Care
What the data says
Among 29 Health Care companies, Viatris is in the top 10% for gross profit. Gross Profit has fluctuated over the past 8 years, ranging from $3.8B in FY2022 to $6.4B in FY2023.
Based on SEC 10-K filings.
$5.0B in FY2025 with a 5-year CAGR of +4.6%. Ranks 3rd among 29 companies in Health Care.
Declined from $6.4B to $5.0B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- +4.6%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 29This company $5.0B Sector average $3.5B
▼
+44.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +4.6%, indicating consistent growth.
- In FY2025, gross profit decreased 10.8% year-over-year.
- Ranks #3 out of 29 companies in the Health Care sector.
- Peak gross profit was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0B | -10.8% |
| FY2024 | $5.6B | -12.7% |
| FY2023 | $6.4B | +69.6% |
| FY2022 | $3.8B | -2.6% |
| FY2021 | $3.9B | -2.6% |
| FY2020 | $4.0B | +2.7% |
| FY2019 | $3.9B | -2.6% |
| FY2018 | $4.0B | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026